Previously, NF1-K1423 was shown to be mutated to Glu and Gln in neurofibromas and solid tumors, and these mutations were shown to result in 200- to 400-fold lower GAP activity than the wild-type (Li et al., 1992). The gene discussed is NF1; the disease is neurofibroma.